Structural Heart Abnormality
Conditions
Brief summary
Structural heart disease refers to a group of cardiac defects other than coronary artery disease. Structural heart intervention is a rapidly growing field in cardiology. In the past decade, there has been paradigm shift in the management of structural heart disease from conventional open-heart surgery to transcatheter interventions. With increasing evidence supporting structural heart interventions including transcatheter aortic valve implantation or transcatheter edge to edge repair, there has important updates in recent guidelines in treating structural heart disease. Besides, new device innovations bloomed over the past few years and had expanded the possible treatment options for high surgical risk patients. Some breakthrough devices had been approved recently by the US Food and Drug Administration and some other devices are occasionally used on compassionate ground. However, there has been lack of data in structural heart interventions in Asia Pacific regions outside Japan \[8\]. In this study, we would like to analyze the epidemiological trends, patient characteristics, procedural outcomes and clinical outcomes of structural heart interventions, and compare them with historical cohorts, matched cohort receiving medical therapy and matched cohort receiving open heart surgeries.
Interventions
The study allows us to understand the trend of transcatheter interventions in structural heart disease, clinical outcomes and allows the comparison of the outcomes of structural heart interventions to medical therapy and surgery at PWH, and to HA hospitals.
Sponsors
Study design
Eligibility
Inclusion criteria
* All patients undergoing structural heart interventions at the Prince of Wales Hospital
Exclusion criteria
* Patients that are not able to consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Procedural success rate | Post-procedure until 1 year post OP | Procedural success rate |
| Procedural safety endpoints | Post-procedure until 1 year post OP | Rate of vascular complication in enrolled subjects , , |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical outcome | 3 months | NTproBNP at 3 months |
| Echocardiogram outcome | 3 months | peri-device leak at post-OP 3 months compared with baseline |
Countries
Hong Kong
Contacts
Chinese University of Hong Kong